Poziotinib hydrochloride
99%
- Product Code: 103415
CAS:
1429757-68-5
| Molecular Weight: | 527.80 g./mol | Molecular Formula: | C₂₃H₂₂Cl₃FN₄O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Poziotinib hydrochloride is primarily used in the treatment of non-small cell lung cancer (NSCLC), particularly in cases where the cancer cells have specific genetic mutations, such as EGFR exon 20 insertions. It functions as a tyrosine kinase inhibitor, targeting and blocking the activity of mutated EGFR proteins that promote cancer cell growth. This helps in slowing down or stopping the progression of the disease. It is often considered when other treatments have not been effective or are unsuitable for the patient. Clinical studies continue to explore its efficacy and potential applications in other types of cancers with similar genetic alterations.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Yellow Powder |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $140.63 |
+
-
|
| 0.050 | 10-20 days | $979.41 |
+
-
|
| 0.250 | 10-20 days | $2,505.27 |
+
-
|
Poziotinib hydrochloride
Poziotinib hydrochloride is primarily used in the treatment of non-small cell lung cancer (NSCLC), particularly in cases where the cancer cells have specific genetic mutations, such as EGFR exon 20 insertions. It functions as a tyrosine kinase inhibitor, targeting and blocking the activity of mutated EGFR proteins that promote cancer cell growth. This helps in slowing down or stopping the progression of the disease. It is often considered when other treatments have not been effective or are unsuitable for the patient. Clinical studies continue to explore its efficacy and potential applications in other types of cancers with similar genetic alterations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :